Vitro. de
Vitro, S. A. B. de C. V., through its subsidiaries, designs, manufactures, processes, distributes, and markets a range of glass products worldwide. The last earnings update was 23 days ago. More info.
Add to Portfolio Compare Print
VITO.F Share Price and Events
7 Day Returns
1 Year Returns
VITO.F Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Vitro. de (VITO.F) | 0% | -13.5% | - | - | -36.1% | -20% |
| US Packaging | -0.6% | -1.2% | 1.7% | 3.9% | 16% | 29.2% |
| US Market | -1% | -3.3% | 0.4% | -0.4% | 30.4% | 37.1% |
1 Year Return vs Industry and Market
- No trading data on VITO.F.
- No trading data on VITO.F.
VITO.F Value
Is Vitro. de undervalued based on future cash flows and its price relative to the stock market?
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Vitro. de
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Vitro. de.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 1 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 9.4% |
| Perpetual Growth Rate | 10-Year US Government Bond Rate | 2.7% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year US Govt Bond Rate | 2.7% |
| Equity Risk Premium | S&P Global | 6% |
| Packaging Unlevered Beta | Simply Wall St/ S&P Global | 0.8 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.803 (1 + (1- 30%) (68.66%)) |
1.127 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
1.13 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (1.127 * 5.96%) |
9.45% |
Discounted Cash Flow Calculation for OTCPK:VITO.F using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Vitro. de is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
Note: Free cash flow to equity valuations ignore the company's cash or debt.
| Levered FCF (USD, Millions) | Source |
Present Value Discounted (@ 9.45%) |
|
|---|---|---|---|
| 2020 | 173.00 | Analyst x1 | 158.07 |
| 2021 | 249.00 | Analyst x1 | 207.87 |
| 2022 | 303.00 | Analyst x1 | 231.12 |
| 2023 | 330.00 | Analyst x1 | 229.99 |
| 2024 | 352.42 | Est @ 6.79% | 224.42 |
| 2025 | 372.07 | Est @ 5.58% | 216.48 |
| 2026 | 389.64 | Est @ 4.72% | 207.14 |
| 2027 | 405.71 | Est @ 4.12% | 197.06 |
| 2028 | 420.74 | Est @ 3.71% | 186.73 |
| 2029 | 435.10 | Est @ 3.41% | 176.43 |
| Present value of next 10 years cash flows | $2,035.31 | ||
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2029
× (1 + g) ÷ (Discount Rate – g)
= $435.10 × (1 + 2.73%) ÷ (9.45% – 2.73%) |
$6,655.20 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= $6,655.20 ÷ (1 + 9.45%)10 |
$2,698.68 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= $2,035.31 + $2,698.68 |
$4,734.00 |
| Equity Value per Share (USD) |
= Total value / Shares Outstanding
= $4,734.00 / 476.03 |
$9.94 |
| Calculation | Result | |
|---|---|---|
| Exchange Rate | USD/MXN
(Reporting currency to currency of BMV:VITRO A) |
19.564 |
| Value per Share (MXN) |
= Value per Share in USD x Exchange Rate (USD/MXN)
= $9.94 x 19.564 |
MX$194.56 |
| Non-primary Listing Adjustment Factor |
1 share in OTCPK:VITO.F
represents 0.04977x
of
BMV:VITRO A
(This could be a different class, a depositary receipt, a different currency, or all of these things.) |
0.04977x |
| Value per Share (Listing Adjusted, USD) |
= Value per Share (MXN) x Listing Adjustment Factor
= MX$ 194.56 x 0.04977 |
$9.68 |
| Value per share (USD) | From above. | $9.68 |
| Current discount | Discount to share price of
$2.12
= -1 x ($2.12 - $9.68) / $9.68 |
78.1% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
Current Discount
Current Discount Checks
- Vitro. de's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Vitro. de's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Vitro. de's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Vitro. de's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2019-06-30) in USD | $0.32 |
| BMV:VITRO A Share Price ** | BMV (2019-08-07) in MXN | MX$42.6 |
| BMV:VITRO A Share Price converted to USD reporting currency | Exchange rate (MXN/ USD) 0.051 | $2.18 |
| United States of America Packaging Industry PE Ratio | Median Figure of 15 Publicly-Listed Packaging Companies | 16.87x |
| United States of America Market PE Ratio | Median Figure of 3,095 Publicly-Listed Companies | 17.23x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Vitro. de.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = BMV:VITRO A Share Price ÷ EPS (both in USD) = 2.18 ÷ 0.32 |
6.83x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Vitro. de is good value based on earnings compared to the US Packaging industry average.
- Vitro. de is good value based on earnings compared to the United States of America market.
Price based on expected Growth
Does
Vitro. de's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 6.83x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts |
17.4%per year |
| United States of America Packaging Industry PEG Ratio | Median Figure of 15 Publicly-Listed Packaging Companies | 1.26x |
| United States of America Market PEG Ratio | Median Figure of 2,124 Publicly-Listed Companies | 1.4x |
*Line of best fit is calculated by linear regression .
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to calculate PEG ratio for Vitro. de, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on
Vitro. de's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2019-06-30) in USD | $3.05 |
| BMV:VITRO A Share Price * | BMV (2019-08-07) in MXN | MX$42.6 |
| BMV:VITRO A Share Price converted to USD reporting currency | Exchange rate (MXN/ USD) 0.051 | $2.18 |
| United States of America Packaging Industry PB Ratio | Median Figure of 20 Publicly-Listed Packaging Companies | 3.4x |
| United States of America Market PB Ratio | Median Figure of 5,265 Publicly-Listed Companies | 1.7x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = BMV:VITRO A Share Price ÷ Book Value per Share (both in USD) = 2.18 ÷ 3.05 |
0.71x |
* Primary Listing of Vitro. de.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Vitro. de is good value based on assets compared to the US Packaging industry average.
Value checks
We assess Vitro. de's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Packaging industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Packaging industry average (and greater than 0)? (1 check) Vitro. de has a total score of 5/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
VITO.F Future Performance
How is Vitro. de expected to perform in the next 1 to 3 years based on estimates from 1 analyst?
- No analysts cover Vitro. de, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Vitro. de's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
- Vitro. de's earnings growth is expected to exceed the United States of America market average.
- Vitro. de's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| OTCPK:VITO.F Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts | 17.4% |
| OTCPK:VITO.F Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts | 4.4% |
| United States of America Packaging Industry Earnings Growth Rate | Market Cap Weighted Average | 15.4% |
| United States of America Packaging Industry Revenue Growth Rate | Market Cap Weighted Average | 3.3% |
| United States of America Market Earnings Growth Rate | Market Cap Weighted Average | 14% |
| United States of America Market Revenue Growth Rate | Market Cap Weighted Average | 7.5% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (1 month ago) | See Below |
| Future Estimates | Average of up to 1 Analyst Estimates (S&P Global) | See Below |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-12-31 | 2,788 | 1 | ||
| 2022-12-31 | 2,710 | 1 | ||
| 2021-12-31 | 2,622 | 1 | ||
| 2020-12-31 | 2,545 | 1 | ||
| 2019-12-31 | 2,424 | 1 |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2019-06-30 | 2,235 | 145 | 148 |
| 2019-03-31 | 2,236 | 202 | 119 |
| 2018-12-31 | 2,238 | 222 | 162 |
| 2018-09-30 | 2,225 | 265 | 176 |
| 2018-06-30 | 2,208 | 318 | 178 |
| 2018-03-31 | 2,202 | 317 | 214 |
| 2017-12-31 | 2,075 | 294 | 194 |
| 2017-09-30 | 1,958 | 327 | 208 |
| 2017-06-30 | 1,634 | 315 | 204 |
| 2017-03-31 | 1,266 | 299 | 199 |
| 2016-12-31 | 963 | 271 | 176 |
| 2016-09-30 | 839 | 265 | 145 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (1 month ago) | See Below |
| Future Estimates | Average of up to 1 Analyst Estimates (S&P Global) | See Below |
All data from Vitro. de Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-12-31 | ||||
| 2022-12-31 | ||||
| 2021-12-31 | ||||
| 2020-12-31 | ||||
| 2019-12-31 |
| Date (Data in USD Millions) | EPS * |
|---|---|
| 2019-06-30 | 0.32 |
| 2019-03-31 | 0.25 |
| 2018-12-31 | 0.34 |
| 2018-09-30 | 0.36 |
| 2018-06-30 | 0.36 |
| 2018-03-31 | 0.45 |
| 2017-12-31 | 0.40 |
| 2017-09-30 | 0.43 |
| 2017-06-30 | 0.42 |
| 2017-03-31 | 0.41 |
| 2016-12-31 | 0.36 |
| 2016-09-30 | 0.30 |
*GAAP earnings excluding extraordinary items.
Future performance checks
We assess Vitro. de's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Vitro. de has a total score of 2/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
VITO.F Past Performance
How has Vitro. de performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Vitro. de has delivered over 20% year on year earnings growth in the past 5 years.
- Vitro. de's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Vitro. de's 1-year earnings growth is negative, it can't be compared to the US Packaging industry average.
Earnings and Revenue History
All data from Vitro. de Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2019-06-30 | 2,234.60 | 147.93 | 359.92 | |
| 2019-03-31 | 2,236.07 | 118.60 | 362.63 | |
| 2018-12-31 | 2,238.38 | 161.74 | 373.61 | |
| 2018-09-30 | 2,224.77 | 175.96 | 361.35 | |
| 2018-06-30 | 2,207.99 | 177.98 | 373.45 | |
| 2018-03-31 | 2,201.96 | 213.58 | 372.36 | |
| 2017-12-31 | 2,075.23 | 193.79 | 350.99 | |
| 2017-09-30 | 1,958.25 | 208.22 | 341.69 | |
| 2017-06-30 | 1,634.38 | 203.71 | 282.07 | |
| 2017-03-31 | 1,265.95 | 199.30 | 220.32 | |
| 2016-12-31 | 963.13 | 175.64 | 162.72 | |
| 2016-09-30 | 838.96 | 145.28 | 142.80 | |
| 2016-06-30 | 864.54 | 33.86 | 149.73 | |
| 2016-03-31 | 884.32 | -10.14 | 153.71 | |
| 2015-12-31 | 819.98 | -69.65 | 143.02 | |
| 2015-09-30 | 763.05 | -132.69 | 156.64 | |
| 2015-06-30 | 753.61 | -94.83 | 157.73 | |
| 2015-03-31 | 744.56 | -93.15 | 161.71 | |
| 2014-12-31 | 755.00 | -87.32 | 161.16 | |
| 2014-09-30 | 1,015.38 | -50.43 | 172.53 | |
| 2014-06-30 | 1,268.80 | 11.20 | 208.35 | |
| 2014-03-31 | 1,468.49 | -17.59 | 238.70 | |
| 2013-12-31 | 1,645.69 | 44.47 | 273.93 | |
| 2013-09-30 | 1,666.72 | -265.55 | 280.40 | |
| 2013-06-30 | 1,712.96 | -260.08 | 292.49 | |
| 2013-03-31 | 1,845.20 | -273.68 | 313.82 | |
| 2012-12-31 | 1,780.38 | 262.07 | 299.81 | |
| 2012-09-30 | 1,782.18 | 586.46 | 319.79 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- Vitro. de has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Vitro. de used its assets more efficiently than the US Packaging industry average last year based on Return on Assets.
- Vitro. de's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
Past performance checks
We assess Vitro. de's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Packaging industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Vitro. de has a total score of 2/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
VITO.F Health
How is Vitro. de's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Vitro. de's finances.
The net worth of a company is the difference between its assets and liabilities.
- Vitro. de is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Vitro. de's cash and other short term assets cover its long term commitments.
Balance sheet
Assets
Liabilities and shares
- High level of physical assets or inventory.
- Debt is covered by short term assets, assets are 1.4x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Vitro. de Company Filings, last reported 1 month ago.
| Date (Data in USD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2019-06-30 | 1,451.09 | 662.45 | 121.24 |
| 2019-03-31 | 1,440.55 | 663.26 | 176.81 |
| 2018-12-31 | 1,468.26 | 720.89 | 290.97 |
| 2018-09-30 | 1,508.99 | 687.11 | 105.68 |
| 2018-06-30 | 1,421.96 | 687.91 | 128.15 |
| 2018-03-31 | 1,438.23 | 688.94 | 160.01 |
| 2017-12-31 | 1,385.04 | 689.47 | 180.48 |
| 2017-09-30 | 1,431.06 | 747.76 | 213.50 |
| 2017-06-30 | 1,371.98 | 747.90 | 173.60 |
| 2017-03-31 | 1,286.19 | 742.73 | 188.87 |
| 2016-12-31 | 1,199.83 | 513.85 | 240.69 |
| 2016-09-30 | 1,166.42 | 497.86 | 925.30 |
| 2016-06-30 | 1,173.15 | 0.00 | 424.61 |
| 2016-03-31 | 1,211.21 | 0.36 | 444.05 |
| 2015-12-31 | 1,169.23 | 0.00 | 414.26 |
| 2015-09-30 | 1,160.54 | 1.26 | 505.95 |
| 2015-06-30 | 565.86 | 1,148.91 | 150.17 |
| 2015-03-31 | 539.68 | 1,177.65 | 169.81 |
| 2014-12-31 | 546.90 | 1,186.53 | 167.39 |
| 2014-09-30 | 645.77 | 1,241.36 | 236.10 |
| 2014-06-30 | 662.49 | 1,257.45 | 218.70 |
| 2014-03-31 | 626.48 | 1,258.11 | 209.27 |
| 2013-12-31 | 488.02 | 1,261.97 | 168.02 |
| 2013-09-30 | 499.56 | 1,254.39 | 184.69 |
| 2013-06-30 | 476.16 | 1,405.50 | 265.09 |
| 2013-03-31 | 523.92 | 1,177.61 | 203.58 |
| 2012-12-31 | 396.56 | 1,151.87 | 188.65 |
| 2012-09-30 | 720.25 | 1,148.93 | 192.66 |
- Vitro. de's level of debt (45.7%) compared to net worth is high (greater than 40%).
- The level of debt compared to net worth has been reduced over the past 5 years (189.8% vs 45.7% today).
- Debt is well covered by operating cash flow (21.9%, greater than 20% of total debt).
- Interest payments on debt are well covered by earnings (EBIT is 6.2x coverage).
Financial health checks
We assess Vitro. de's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Vitro. de has a total score of 5/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
VITO.F Dividends
What is Vitro. de's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
$2,000 of
Vitro. de
shares you are expected to receive
$96
in your first year as a dividend.
Dividend Amount
- Vitro. de's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.49%).
- Vitro. de's dividend is above the markets top 25% of dividend payers in United States of America (3.84%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 1 Analyst Estimates (S&P Global) | See Below |
| United States of America Packaging Industry Average Dividend Yield | Market Cap Weighted Average of 13 Stocks | 2.6% |
| United States of America Market Average Dividend Yield | Market Cap Weighted Average of 2009 Stocks | 2.5% |
| United States of America Minimum Threshold Dividend Yield | 10th Percentile | 0.8% |
| United States of America Bottom 25% Dividend Yield | 25th Percentile | 1.5% |
| United States of America Top 25% Dividend Yield | 75th Percentile | 3.8% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in $) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2023-12-31 | ||
| 2022-12-31 | ||
| 2021-12-31 | ||
| 2020-12-31 | ||
| 2019-12-31 |
| Date (Data in $) | Dividend per share (annual) | Avg. Yield (%) |
|---|---|---|
| 2019-04-30 | 0.104 | 4.214 |
| 2019-02-22 | 0.104 | 4.021 |
| 2019-02-19 | 0.104 | 3.842 |
| 2018-07-27 | 0.065 | 2.349 |
| 2018-02-27 | 0.065 | 2.085 |
| 2018-02-19 | 0.065 | 1.757 |
| 2017-07-26 | 0.052 | 1.321 |
| 2017-03-30 | 0.052 | 1.263 |
| 2017-02-22 | 0.052 | 1.388 |
| 2016-04-29 | 1.600 | 51.142 |
| 2016-04-14 | 1.600 | 47.834 |
| 2015-10-28 | 3.108 | 101.243 |
| 2010-01-15 | 0.000 | 0.000 |
| 2009-10-30 | 0.000 | 0.000 |
| 2009-10-28 | 0.000 | 0.000 |
| 2009-07-29 | 0.000 | 0.000 |
| 2009-07-01 | 0.000 | 0.000 |
| 2008-12-31 | 0.000 | 0.000 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Vitro. de has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
- Vitro. de has only been paying a dividend for 4 years, and since then dividends per share have fallen.
Income/ dividend checks
We assess Vitro. de's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Vitro. de afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Vitro. de has a total score of 3/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
VITO.F Management
CEO
| AGE | 44 |
| TENURE AS CEO | 6.4 years |
CEO Bio
Mr. Adrian G. Sada Cueva serves as the Chief Executive Officer. Mr. Sada Cueva has been Chief Executive Officer of Vitro, S.A.B. de C.V. since March 20, 2013. He serves as Vice President of Administration & Finance of Vitro’s Glasss Containers Business Unit. He served as the President at Compania Vidriera, S.A. de C.V. He served as the President of The Glass Containers Business Unit at Vitro, S.A.B. de C.V. from 2012 to 2013. At Vitro, he served as the President of Envases from 2012 to 2013, Operating Director of Envases from 2011, Director General of Administration & Finance of Envases from 2009 to 2010. He served as General Manager of Vitro Automotriz from 2006 to 2008. He served as the President of Compañía Vidriera, S.A. De C.V. He has been a Director of Vitro, S.A.B. de C.V from 2010. He has been an Independent Director at Nemak, S.A.B. de C.V. (Also known as: Tenedora Nemak, S.A. de C.V.) from June 2015. He has also served as Director of Vitro Cristalglass (Spain), Managing Director of Vitro Automotriz, Director of Internal Restructuring, Director of Administration and Finance and Managing Director of Vitro’s packaging business. He has been an Independent Director of Grupo Financiero Banorte, S.A.B. de C.V. from April 2013. He serves as a Director of Club Industrial de Monterrey, Banco Mercantil del Norte, CAINTRA Nuevo León, Club Deportivo Cazadores Monterrey, Empresas Comegua S.A., Confederación Patronal de la República Mexicana (Coparmex) Nuevo León, Consejo General de la Universidad de Monterrey, Pronatura Noreste A.C., Organización Vida Silvestre A.C. and Salinas del Pacífico, S.A. de C.V. He is a Board Member at Cámara de la Industria de Transformación (CAINTRA) of Nuevo León. He is also a Member of The Boards of Directors of Civil Associations, Wildlife Organization and Salinas of The Pacific. He served as a Board Member Compañía Minera Autlán, S.A.B. de C.V. since 2017. Mr. Sada Cueva has a degree in Business Administration from ITESM and obtained an MBA from Stanford Graduate School of Business.
CEO Compensation
- Insufficient data for Adrian G. to compare compensation growth.
- Insufficient data for Adrian G. to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure
Average tenure and age of the Vitro. de management team in years:
- The average tenure for the Vitro. de management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team
Claudio Del Valle Cabello
Chief Administrative & Financial Officer
59
16.6 yrs
Adrian G. Sada Cueva
CEO & Director
44
6.4 yrs
Adrián Meouchi
Vice President of Investor Relations
Alejandro Francisco Sánchez Mújica
Secretary of the Board
65
12.3 yrs
Raúl Rangel Hinojosa
Legal & Financial Advisor
70
Board of Directors Tenure
Average tenure and age of the Vitro. de board of directors in years:
- The average tenure for the Vitro. de board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors
Adrián G. Sada González
Chairman of the Board
75
Adrian G. Sada Cueva
CEO & Director
44
9.6 yrs
Joaquín Vargas Guajardo
Director
65
19.6 yrs
Tomás Roberto González Sada
Director
76
39.6 yrs
Jaime José Serra Puche
Director
68
21.6 yrs
Ricardo Martin Bringas
Director
59
12.6 yrs
Jaime Rico Garza
Director
62
11.6 yrs
Guillermo Martínez
Director
71
9.6 yrs
Mario Martín Laborín Gómez
Director
67
9.6 yrs
Álvaro Fernández Garza
Director
51
8.6 yrs
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price ($) | Value ($) | |
|---|---|---|---|---|---|---|---|---|---|---|
Management checks
We assess Vitro. de's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Vitro. de has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
VITO.F Company Info
Description
Vitro, S. A. B. de C. V., through its subsidiaries, designs, manufactures, processes, distributes, and markets a range of glass products worldwide. It operates in two segments, Flat Glass and Glass Containers. The Flat Glass segment provides flat glass products for the construction and automotive industries; and carbonate and sodium bicarbonate. The Glass Containers segment offers glass containers for the cosmetics, fragrances and toiletries, and pharmaceuticals markets; and precision components, as well as machineries and molds for the glass industry. In addition, it provides chemical products and raw materials for use in the glass, detergents, water treatment, oil, roads and highway thawing, food, and poultry and livestock markets; and provides engineering, automation, and other services. Vitro, S. A. B. de C. V. was founded in 1909 and is based in San Pedro Garza García, Mexico.
Details
| Name: | Vitro, S.A.B. de C.V. |
| VITO.F | |
| Exchange: | OTCPK |
| Founded: | 1909 |
| MX$1,036,541,725 | |
| 476,033,004 | |
| Website: | http://www.vitro.com |
| Address: |
Vitro, S.A.B. de C.V. Avenida Ricardo Margáin Zozaya No. 400, Colonia Valle del Campestre, San Pedro Garza García, Nuevo Leon, 66265, Mexico |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| BMV | VITRO A | Series A Common Stock | Bolsa Mexicana de Valores | MX | MXN | 21. Aug 1991 | |
| OTCPK | VITO.F | Series A Common Stock | Pink Sheets LLC | US | USD | 21. Aug 1991 |
Number of employees
Current staff
Industry
| Metal and Glass Containers | |
| Materials |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/08/17 23:50 |
| End of day share price update: | 2019/08/07 00:00 |
| Last estimates confirmation: | 2019/03/06 |
| Last earnings filing: | 2019/07/25 |
| Last earnings reported: | 2019/06/30 |
| Last annual earnings reported: | 2018/12/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
